Align Technology | ALGN - 债务



金融业
股票价格
USD
资产
USD 6.42B
现金及等价物
USD 1.1B
销售成本
USD 298.76M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 116.04M
EBIT
USD 191.32M
EBITDA
USD 229.14M
员工
20.95K
EPS每股收益
USD 2.64
股本和储备
USD 4.23B
销售毛利
USD 757.43M
债务利息支出
USD 6.93M
利息收入
USD 3.91M
贷款资金
USD 0
市值
USD 11.83B
净收入
USD 108.29M
营业费用
USD 864.87M
营业利润
USD 191.32M
普通股股本
USD 71.62M
PE价格收益
21.81
税前利润
USD 148.69M
销售收入
USD 1.06B
销售和管理费用
USD 462.67M
股票
USD 212.24M
贸易债权人
USD 109.84M
应收帐款人
USD 1.15B


债务 更改 日
3M USD 12.55B 5M 2026-06
Align Technology USD 116.04M 1.6M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Bruker USD 1.82B 153.5M 2026-06
Cardinal Health USD 8.89B 30M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cooper Companies USD 2.5B 5.6M 2025-12
CVS Health USD 61.41B 16.94B 2026-06
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Dexcom USD 1.24B 900K 2026-03
Henry Schein USD 3.81B 64M 2026-06
Idexx Laboratories USD 1.1B 9.37M 2026-06
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
IQVIA Holdings USD 16.24B 408M 2026-06
McKesson USD 8.61B 10M 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Revvity USD 3.35B 48.03M 2026-03
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.19B 32M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Veeva Systems USD 103.07M 7.21M 2026-03
Waters USD 5.57B 4.08B 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06
Zoetis USD 9.24B 0 2026-03